Update on new treatments and developments in childhood brain tumors

Current Opinion in Pediatrics

Volumn 19, Issue 6, 2007, Pages 670-674

  Partap, Sonia ^a,b   Fisher, Paul Graham ^a  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD CANCER INSTITUTE   (United States)

Author keywords

Brain tumor; Central nervous system; Childhood cancer; Late effects

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETOPOSIDE; LOMUSTINE; VINCRISTINE;

ATAXIA; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER GENETICS; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; COGNITIVE DEFECT; CRANIAL NERVE PARALYSIS; CRYING; DYSPHAGIA; EPENDYMOMA; GENE OVEREXPRESSION; GLIOMA; HISTOLOGY; HUMAN; LONG TERM CARE; MEDULLOBLASTOMA; MENTAL INSTABILITY; MOLECULAR GENETICS; MUSCLE HYPOTONIA; MUTISM; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; SCIENTIST; SURVIVAL RATE; SURVIVAL TIME; TREATMENT FAILURE; TREATMENT OUTCOME;

ANIMALS; BRAIN NEOPLASMS; CHILD; EPENDYMOMA; GLIOMA; HUMANS; NEOPLASMS, SECOND PRIMARY; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RADIOTHERAPY; RADIOTHERAPY DOSAGE; SURVIVORS;

EID: 36348979883     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOP.0b013e3282f0eafa     Document Type: Review

References (31)

1. Central Brain Tumor Registry of the US. Statistical report: primary brain tumors in the United States, 1998-2002. Hinsdale: Central Brain Tumor Registry of the US; 2005.
2. Packer RJ, Goldwein J, Nicholson HS, et al. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: a Children's Cancer Group study. J Clin Oncol 1999; 17:2127-2136.
3. Albright AL, Wisoff JH, Zeltzer PM, et al. Effects of medulloblastoma resections on outcome in children: a report from the Children's Cancer Group. Neurosurgery 1996; 38:265-271.
4. Robertson PL, Muraszko KM, Holmes EJ, et al. Incidence and severity of postoperative cerebellar mutism syndrome in children with medulloblastoma: a prospective study by the Children's Oncology Group. J Neurosurg 2006; 105:444-451.
5. Packer RJ, Gajjar A, Vezina G, et al. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol 2006; 24:4202-4208. Excellent prospective randomized clinical trial that compared low-dose CSRT in average-risk medulloblastoma with two different chemotherapeutic regimens with similar EFS outcomes. It reveals that new regimens to reduce harmful side-effects may be possible in the future.
6. Gajjar A, Chintagumpala M, Ashley D, et al. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. Lancet Oncol 2006; 7:813-820. This comprehensive study illustrates the possible reduction in total chemotherapy duration and dose for a common pediatric brain tumor.
7. Packer RJ, Sutton LN, Elterman R, et al. Outcome for children with medulloblastoma treated with radiation, cisplatin, CCNU, and vincristine chemotherapy. J Neurosurg 1994; 81:690-698.
8. Eberhart CG, Kepner JL, Goldthwaite PT, et al. Histopathologic grading of medulloblastomas: a Pediatric Oncology Group study. Cancer 2002; 94:552-560.
9. Ellison DW, Onilude OE, Lindsey JC, et al. β-catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group brain tumour committee. J Clin Oncol 2005; 23:7951-7957.
10. McCall TD, Pedone CA, Fults DW. Apoptosis suppression by somatic cell transfer of bcl-2 promotes sonic hedgehog-dependent medulloblastoma formation in mice. Cancer Res 2007; 67:5179-5185.
11. Rickert CH, Paulus W. Epidemiology of central nervous system neoplasms in childhood and adolescence based on the new WHO classification. Childs Nerv Syst 2001; 17:503-511.
12. Korshunov A, Neben K, Wrobel G, et al. Gene expression patterns in ependymomas correlate with tumor location, grade, and patient. Am J Pathol 2003; 163:1721-1727.
13. Merchant TE, Mulhern RK, Krasin MJ, et al. Preliminary results from a phase II trial of conformal radiation therapy and evaluation of radiation-related CNS effects for pediatric patients with localized ependymoma. J Clin Oncol 2004; 22:3156-3162.
14. Goldwein JW, Glauser TA, Packer RJ, et al. Recurrent intracranial ependymomas in children: Survival, patterns of failure, and prognostic factors. Cancer 1990; 66:557-563.
15. Sowar K, Straessle J, Donson AM, et al. Predicting which children are at risk for ependymoma relapse. J Neurooncol 2006; 78:41-46.
16. Tabori U, Ma J, Carter M, et al. Human telomere reverse transcriptase expression predicts progression and survival in pediatric intracranial ependymoma. J Clin Oncol 2006; 24:1522-1528.
17. Modena P, Lualdi E, Facchinetti F. Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics. J Clin Oncol 2006; 24:5223-5233. Provides insights on novel molecular profiling techniques that may help characterize ependymoma more accurately in the future.
18. Taylor MD, Poppleton H, Fuller C, et al. Radial glia cells are candidate stem cells of ependymoma. Cancer Cell 2005; 8:323-355.
19. Donaldson SS, Laningham F, Fisher PG. Advances toward an understanding of brainstem gliomas. J Clin Oncol 2006; 24:1266-1272.
20. Greenberg ML, Fisher PG, Freeman C, et al. Etoposide, vincristine, and cyclosporin A with standard-dose radiation in newly diagnosed diffuse intrinsic brainstem gliomas: a Pediatric Oncology Group phase I study. Pediatr Blood Cancer 2005; 45:644-648.
21. Korones DN, Fisher PG, Kretschmar C, et al. Treatment of children with diffuse intrinsic brain stem glioma with radiotherapy, vincristine, and oral VP-16: a Children's Oncology Group phase II study. Pediatr Blood Cancer 2007. [Epub ahead of print].
22. Kesari S, Ramakrishna N, Sauvageot C, et al. Targeted molecular therapy of malignant gliomas. Curr Neurol Neurosci Rep 2005; 5:186-197.
23. Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006; 355:1572-1582. Tracks survivors of childhood cancer through a retrospective cohort study known as the Childhood Cancer Survivor Study between 1970 and 1986, revealing a significant increase in chronic ailments when compared with their siblings.
24. Dickerman JD. The late effects of childhood cancer therapy. Pediatrics 2007; 119:554-568. Discusses the difficulties that childhood cancer survivors face according to organ system. Recommendations are also suggested for monitoring these patients.
25. Landier W, Bhatia S, Eshelman DA, et al. Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. J Clin Oncol 2004; 22:4979-4990.
26. Neglia JP, Robison LL, Stovall M, et al. New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 2006; 98:1528-1537. This large retrospective study compares patients treated for childhood malignancies with control subjects and identifies a significant risk of secondary neoplasms. The correlation with radiation dose and exposure is striking.
27. Hijiya N, Hudson MM, Lensing S, et al. Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukaemia. JAMA 2007; 297:1207-1215. Provides insight from one institution's experience of a common and treatable pediatric cancer and the long-term effects of secondary malignancies.
28. Morris BE, Gajjar A, Okuma JO, et al. Survival and late mortality in long-term survivors of pediatric CNS tumors. J Clin Oncol 2007; 25:1532-1538. This article reviews that not only is progressive disease a problem among pediatric brain tumor survivors, but the long-term sequelae of panhypopituitarism and other less obvious chronic conditions are ongoing issues.
29. Bowers DC, Liu Y, Leisenring W, et al. Late-occurring stroke among long-term survivors of childhood leukemia and brain tumors: a report from the childhood cancer survivor study. J Clin Oncol 2006; 24:5277-5282. Reveals stroke as a significant source of morbidity in the survivors of pediatric cancer and the risk associated with irradiation.
30. Kiehna EN, Mulhern RK, Li C, et al. Changes in attentional performance of children and young adults with localized primary brain tumors after conformal radiation therapy. J Clin Oncol 2006; 24:5283-5290.
31. Bhat SR, Goodwin TL, Burwinkle TM, et al. Profile of daily life in children with brain tumors: an assessment of health-related quality of life. J Clin Oncol 2005; 23:5493-5500.